<DOC>
	<DOCNO>NCT00180791</DOCNO>
	<brief_summary>The purpose study evaluate efficacy combination surgery , conventional chemotherapy , sequential high-dose chemotherapy peripheral blood stem cell transplantation reduce dose radiation therapy high-risk PNET brain tumor .</brief_summary>
	<brief_title>High Risk Primitive Neuroectodermal ( PNET ) Brain Tumors Childhood</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>Medulloblastoma patient less 5 year age Brain PNET patient less 10 year age Histologically document diagnosis Body weight &gt; 8 kg Parents ' refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Brain PNET</keyword>
</DOC>